Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-25-000022
Filing Date
2025-02-13
Accepted
2025-02-13 06:06:56
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 6-K form6k_021325.htm 6-K 58786
  Complete submission text file 0001395064-25-000022.txt   59792
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 25616989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)